While tardive dyskinesia is most often caused by sustained exposure to antipsychotics, any drug that significantly blocks dopamine receptors can be a culprit, said Demian Rose, MD, PhD, of the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription ...

Tardive dyskinesia, or TD, is a drug-induced movement disorder that can occur in individuals taking certain medications that block dopamine receptors in the brain. Most commonly, cases of TD are ...

TD often decreases patients’ quality of life through its effects on their physical, emotional, cognitive, and psychosocial well-being. An easy-to-use tool to assess the impact of TD might allow ...

Tardive dyskinesia is a common side effect caused by antipsychotic use. It is a neurological disorder characterized by involuntary, repetitive movements, often involving the face, mouth, tongue, and ...

Deutetrabenazine (Austedo, Teva Pharmaceuticals) significantly reduced abnormal involuntary movements in patients with tardive dyskinesia (TD) caused by antipsychotic medications and was generally ...

SAN DIEGO, April 25, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that once-daily INGREZZA ® (valbenazine) capsules, the first U.S. Food and Drug Administration ...

Tardive dyskinesia is a medication-induced movement disorder. It's typically caused by certain classes of medicines that block dopamine receptors in the brain. The typical offenders are a class of ...

SAN DIEGO, June 2, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented findings from a meta-analysis of three long-term studies evaluating INGREZZA ® (valbenazine) ...

Terrell Davis, TD, has been a mental health advocate ever since going public about his own mental health challenges. That's ...